Difficulty: Medium
Average Score: 77%
Practice
Main effect of sulphinpyrazone in hyperuricaemia is
Correct answer
B
Rationale
The main effect of sulfinpyrazone in hyperuricemia is to promote the elimination of urate. Sulfinpyrazone is a uricosuric agent that works by inhibiting the reabsorption of uric acid in the renal tubules, thus increasing the excretion of uric acid in the urine. This helps lower the levels of uric acid in the blood, which is beneficial in conditions like gout where high levels of uric acid can lead to the formation of urate crystals in the joints.
Option A, "Suppress the symptoms," is incorrect because sulfinpyrazone does not directly suppress the symptoms of hyperuricemia. It acts on the underlying cause by increasing the elimination of uric acid.
Option C, "Prevent urate synthesis," is also incorrect as sulfinpyrazone does not inhibit the synthesis of uric acid. Instead, it primarily enhances the excretion of uric acid that is already present in the body.
Option D, "All of the above," is incorrect as sulfinpyrazone's main mechanism of action is to promote the elimination of urate, not to suppress symptoms or prevent urate synthesis.
In an educational context, understanding the specific mechanisms of action of medications used in the treatment of hyperuricemia is crucial for healthcare professionals to make informed decisions about patient care. Knowing that sulfinpyrazone is a uricosuric agent that promotes urate elimination can guide clinicians in selecting the most appropriate treatment for patients with hyperuricemia and related conditions like gout.
Option A, "Suppress the symptoms," is incorrect because sulfinpyrazone does not directly suppress the symptoms of hyperuricemia. It acts on the underlying cause by increasing the elimination of uric acid.
Option C, "Prevent urate synthesis," is also incorrect as sulfinpyrazone does not inhibit the synthesis of uric acid. Instead, it primarily enhances the excretion of uric acid that is already present in the body.
Option D, "All of the above," is incorrect as sulfinpyrazone's main mechanism of action is to promote the elimination of urate, not to suppress symptoms or prevent urate synthesis.
In an educational context, understanding the specific mechanisms of action of medications used in the treatment of hyperuricemia is crucial for healthcare professionals to make informed decisions about patient care. Knowing that sulfinpyrazone is a uricosuric agent that promotes urate elimination can guide clinicians in selecting the most appropriate treatment for patients with hyperuricemia and related conditions like gout.